drugset
drugset / Trial / NCT04714073

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood

NCT04714073 ↗

Phase 1 Completed 14 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

To investigate the pharmacokinetics of a single oral dose of BI 706321 when given alone or in combination with itraconazole.

Timeline

Start
2021-02-11
Primary completion
2021-04-30
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 706321 Unknown 2 mg Oral
Subject Itraconazole Small molecule 200 mg Oral

Indications

No indication recorded.